GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SMS Pharmaceuticals Ltd (BOM:532815) » Definitions » Cyclically Adjusted PS Ratio

SMS Pharmaceuticals (BOM:532815) Cyclically Adjusted PS Ratio : 3.04 (As of Jun. 04, 2025)


View and export this data going back to 2007. Start your Free Trial

What is SMS Pharmaceuticals Cyclically Adjusted PS Ratio?

As of today (2025-06-04), SMS Pharmaceuticals's current share price is ₹259.95. SMS Pharmaceuticals's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ₹85.55. SMS Pharmaceuticals's Cyclically Adjusted PS Ratio for today is 3.04.

The historical rank and industry rank for SMS Pharmaceuticals's Cyclically Adjusted PS Ratio or its related term are showing as below:

BOM:532815' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.75   Med: 1.73   Max: 4.29
Current: 3.04

During the past years, SMS Pharmaceuticals's highest Cyclically Adjusted PS Ratio was 4.29. The lowest was 0.75. And the median was 1.73.

BOM:532815's Cyclically Adjusted PS Ratio is ranked worse than
61.11% of 738 companies
in the Drug Manufacturers industry
Industry Median: 2.155 vs BOM:532815: 3.04

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

SMS Pharmaceuticals's adjusted revenue per share data for the three months ended in Mar. 2025 was ₹29.177. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₹85.55 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


SMS Pharmaceuticals Cyclically Adjusted PS Ratio Historical Data

The historical data trend for SMS Pharmaceuticals's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SMS Pharmaceuticals Cyclically Adjusted PS Ratio Chart

SMS Pharmaceuticals Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.78 1.29 0.75 2.11 2.49

SMS Pharmaceuticals Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.11 2.59 4.04 2.78 2.49

Competitive Comparison of SMS Pharmaceuticals's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - General subindustry, SMS Pharmaceuticals's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SMS Pharmaceuticals's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, SMS Pharmaceuticals's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where SMS Pharmaceuticals's Cyclically Adjusted PS Ratio falls into.


;
;

SMS Pharmaceuticals Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

SMS Pharmaceuticals's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=259.95/85.55
=3.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SMS Pharmaceuticals's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, SMS Pharmaceuticals's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=29.177/157.5517*157.5517
=29.177

Current CPI (Mar. 2025) = 157.5517.

SMS Pharmaceuticals Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 16.274 94.103 27.247
201409 15.954 96.780 25.972
201412 17.529 96.780 28.536
201503 18.693 97.163 30.311
201506 14.638 99.841 23.099
201509 18.057 101.753 27.959
201512 18.332 102.901 28.068
201603 20.225 102.518 31.082
201606 17.210 105.961 25.589
201609 21.117 105.961 31.398
201703 0.000 105.196 0.000
201803 0.000 109.786 0.000
201806 14.833 111.317 20.994
201809 15.954 115.142 21.830
201812 11.934 115.142 16.330
201903 11.858 118.202 15.806
201906 13.873 120.880 18.082
201909 13.955 123.175 17.850
201912 9.505 126.235 11.863
202003 10.904 124.705 13.776
202006 13.335 127.000 16.543
202009 15.422 130.118 18.674
202012 17.605 130.889 21.191
202103 19.996 131.771 23.908
202106 19.248 134.084 22.617
202109 20.636 135.847 23.933
202112 14.476 138.161 16.508
202203 6.631 138.822 7.526
202206 7.615 142.347 8.428
202209 19.052 144.661 20.750
202212 17.393 145.763 18.800
202303 17.323 146.865 18.584
202306 15.937 150.280 16.708
202309 19.755 151.492 20.545
202312 19.130 152.924 19.709
202403 29.226 153.035 30.089
202406 19.459 155.789 19.679
202409 23.304 157.882 23.255
202412 20.432 158.323 20.332
202503 29.177 157.552 29.177

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


SMS Pharmaceuticals  (BOM:532815) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


SMS Pharmaceuticals Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of SMS Pharmaceuticals's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


SMS Pharmaceuticals Business Description

Traded in Other Exchanges
Address
Plot No. 72, H.No. 8-2-334/3&4, Road. No. 5, Opposite SBI Executive Enclave, Banjara Hills, Hyderabad, TG, IND, 500034
SMS Pharmaceuticals Ltd is a drug manufacturing company. It is engaged in the manufacturing and sale of active pharmaceutical ingredients (API's), and their intermediates viz. Metal Acetylacetonates, Diltiazem Hydrochloride and Taxol C-13 Side Chain. Its product portfolio includes drugs for anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, anti-viral, among others.

SMS Pharmaceuticals Headlines

No Headlines